Clinical Trial Detail

NCT ID NCT03614728
Title Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors GlaxoSmithKline

chronic myelomonocytic leukemia

myelodysplastic syndrome

acute myeloid leukemia


Azacitidine + GSK3326595


Age Groups: adult senior

Additional content available in CKB BOOST